Johnson & Johnson Revenue from International market

Net Sales of Johnson & Johnson Outside US 2001-2021

Amounts are in $millions.

YearInternational Revenues  ($m)
2021$46,619
2020$39,451
2019$39,962
2018$39,697 
2017$36,587
2016$34,079
2015$34,387
2014$39,549
2013$39,402 
2012$7,394
2011$36,122
2010$32,137
2009$31,008
2008$31,438  
2007$28,651
2006$23,549
2005$22,137
2004$19,578
2003$16,588
2002$13,843
2001$12,492

Johnson and Johnson generated $46,619 million from the international markets in 2021 compared to $39,451 million in 2020. Its sales in the international markets grew 18.2% in 2021 compared to 2020. In 2021, its net revenues in the US market were $4,156 million compared to $43,133 million in 2020. 

Net Revenue of Johnson & Johnson from US market in 2018 was $41,884 million, having risen from $39,863 million in 2017. US accounted for more than 50% of the brand's net sales in 2018. Its net revenue from international markets in 2018 reached $39,697 million, rising from $36,587 million in 2017. Total revenue of the brand was $81,581 million in 2018.

Johnson and Johnson makes and sells a  broad range of healthcare products across the world. As of 2021, it had approximately 141,700 full time employees. The company was incorporated in the state of New Jersey in 1887. It has organized its business into three main segments including Consumer Health, Pharmaceutical and Medical Devices. Its largest market is the United States.